Acrivon Therapeutics, Inc. Common Stock (ACRV) — Long-term Investment Intensity
Acrivon Therapeutics, Inc. Common Stock (ACRV) has a Long-term Investment Intensity of 3.5% as of September 2025. Long-term investments of $5.11 Million represent 3.5% of total assets of $145.30 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Acrivon Therapeutics, Inc. Common Stock liquidity resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Acrivon Therapeutics, Inc. Common Stock Long-term Investment Intensity (2022–2024)
This chart shows how Acrivon Therapeutics, Inc. Common Stock's Long-term Investment Intensity has evolved across 2 annual periods from 2022 to 2024. As of September 2025, the intensity stands at 3.5%, reflecting long-term investments of $5.11 Million against total assets of $145.30 Million USD. For the complete balance sheet picture, see ACRV total assets.
Annual Long-term Investment Intensity for Acrivon Therapeutics, Inc. Common Stock (2022–2024)
The table below presents the year-by-year Long-term Investment Intensity for Acrivon Therapeutics, Inc. Common Stock from 2022 to 2024, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read ACRV current and long-term liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 2.6% | $5.09 Million | $196.59 Million | ▼ -20.5 pp |
| 2022 | 23.1% | $41.88 Million | $181.23 Million | — |